UPCLIXIOR
Live / Applied — Non-final action mailed (as of 21 Mar 2026)
What this means for you
Not registered yet, but its 10 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99488513
- Mark type
- Stylized text
- Filed
- 10 Nov 2025
- Attorney of record
- Marilyn F. Kelly
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases, central nervous system diseases, metabolic disorders, stroke, cancer, inflammatory diseases, respiratory diseases, infectious diseases, auto-immune diseases, solid organ transplant rejection, autoinflammatory disease, blood disease, multiple sclerosis, ulcerative colitis, cystic fibrosis, arthritis, and musculoskeletal and skin disease; Antivirals; Antibodies for medical purposes; Biological preparations for the treatment of cancer; Anticoagulants; Stem cells for medical purposes; Radiopharmaceutical preparations for the treatment of cancer and solid tumors; Diagnostic radiopharmaceutical preparations; Diagnostic preparations for medical purposes
Owner
- Bristol- Myers Squibb Company, Princeton, NJ, US
Prosecution history
- 21 Mar 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 21 Mar 2026 — NON-FINAL ACTION E-MAILED
- 21 Mar 2026 — NON-FINAL ACTION WRITTEN
- 20 Mar 2026 — ASSIGNED TO EXAMINER
- 16 Mar 2026 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 11 Dec 2025 — TEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED
- 11 Dec 2025 — TEAS VOLUNTARY AMENDMENT RECEIVED
- 10 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 10 Nov 2025 — NEW APPLICATION ENTERED